These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1412647)

  • 1. Relative efficacy of melarsen oxide compared with mel Cy (Cymelarsan) when used in combination with difluoromethylornithine in the treatment of trypanosomiasis of the central nervous system.
    Jennings FW
    Trans R Soc Trop Med Hyg; 1992; 86(3):257-8. PubMed ID: 1412647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination chemotherapy of drug-resistant Trypanosoma brucei rhodesiense infections in mice using DL-alpha-difluoromethylornithine and standard trypanocides.
    Bacchi CJ; Nathan HC; Yarlett N; Goldberg B; McCann PP; Sjoerdsma A; Saric M; Clarkson AB
    Antimicrob Agents Chemother; 1994 Mar; 38(3):563-9. PubMed ID: 8203855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of an arsenical compound (RM 110, mel Cy, Cymelarsan) against susceptible and drug-resistant Trypanosoma brucei brucei and T.b. evansi.
    Zweygarth E; Kaminsky R
    Trop Med Parasitol; 1990 Jun; 41(2):208-12. PubMed ID: 2382101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy of CNS-trypanosomiasis: the combined use of diminazene aceturate or pentamidine with DL-alpha-difluoromethylornithine (DFMO).
    Jennings FW
    Trop Med Parasitol; 1992 Jun; 43(2):106-9. PubMed ID: 1519020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary observations on the efficacy of mel Cy (Cymelarsan) in domestic animals infected with stocks of Trypanosoma brucei brucei and T.b. evansi.
    Zweygarth E; Ngeranwa J; Kaminsky R
    Trop Med Parasitol; 1992 Dec; 43(4):226-8. PubMed ID: 1293725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DL-alpha-difluoromethylornithine (DFMO)-Berenil combination: therapeutic and prophylactic activity against Trypanosoma brucei brucei infection in mice.
    Onyeyili PA; Egwu GO; Zaria LT; Orjiude BA
    Rev Elev Med Vet Pays Trop; 1991; 44(4):443-5. PubMed ID: 1843826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination chemotherapy of CNS trypanosomiasis.
    Jennings FW
    Acta Trop; 1993 Sep; 54(3-4):205-13. PubMed ID: 7902658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy of CNS-trypanosomiasis: combination chemotherapy with a 5-nitroimidazole (MK 436), an arsenical (Cymelarsan) and suramin.
    Jennings FW
    Trop Med Parasitol; 1991 Sep; 42(3):157-60. PubMed ID: 1801135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of DL-alpha-difluoromethylornithine against susceptible and drug-resistant Trypanosoma brucei brucei.
    Zweygarth E; Kaminsky R
    Acta Trop; 1991 Jan; 48(3):223-32. PubMed ID: 1671624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of combinations of difluoromethylornithine and bleomycin in a mouse model of central nervous system African trypanosomiasis.
    Clarkson AB; Bacchi CJ; Mellow GH; Nathan HC; McCann PP; Sjoerdsma A
    Proc Natl Acad Sci U S A; 1983 Sep; 80(18):5729-33. PubMed ID: 6193522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The importance of 2,3-dimercaptopropinol (British anti-lewisite, BAL) in the trypanocidal activity of topical melarsoprol.
    Jennings FW; Atouguia JM; Murray M
    Acta Trop; 1996 Oct; 62(2):83-9. PubMed ID: 8988309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental infection of goats with Trypanosoma brucei ssp. and effects of treatment with suramin and Mel-B.
    Wellde BT; Reardon MJ; Chumo DA; Muriithi RM; Towett S; Mwangi J
    Ann Trop Med Parasitol; 1989 Aug; 83 Suppl 1():161-9. PubMed ID: 2619390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy of trypanosomiasis: the potentiation of antimonial compounds by difluoromethylornithine (DFMO).
    Jennings FW
    Trop Med Parasitol; 1991 Jun; 42(2):135-8. PubMed ID: 1654590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eflornithine. A new drug in the treatment of sleeping sickness.
    Van Bogaert I; Haemers A
    Pharm Weekbl Sci; 1989 Jun; 11(3):69-75. PubMed ID: 2505225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of combination of DFMO and diminazene aceturate in the treatment of late stage Trypanosoma brucei brucei infection in rats.
    Onyeyili PA; Onwualu JE
    Trop Med Parasitol; 1991 Jun; 42(2):143-5. PubMed ID: 1896772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary efficacy trial of Cymelarsan in mice artificially infected with Trypanosoma brucei brucei isolated from a dog in Zambia.
    Syakalima M; Yasuda J; Hashimoto A
    Jpn J Vet Res; 1995 Sep; 43(2):93-7. PubMed ID: 7474644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential sensitivity of Trypanosoma brucei rhodesiense isolates to in vitro lysis by arsenicals.
    Yarlett N; Goldberg B; Nathan HC; Garofalo J; Bacchi CJ
    Exp Parasitol; 1991 Feb; 72(2):205-15. PubMed ID: 1849084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cymelarsan in the treatment of buffaloes naturally infected with Trypanosoma evansi in south China.
    Lun ZR; Min ZP; Huang D; Liang JX; Yang XF; Huang YT
    Acta Trop; 1991 Aug; 49(3):233-6. PubMed ID: 1685304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gambian trypanosomiasis and synergism between melarsoprol and eflornithine: first case report.
    Simarro PP; Asumu PN
    Trans R Soc Trop Med Hyg; 1996; 90(3):315. PubMed ID: 8758090
    [No Abstract]   [Full Text] [Related]  

  • 20. [Arsenical resistance and difluoromethylornithine in the treatment of human African trypanosomiasis].
    Kazyumba GL; Ruppol JF; Tshefu AK; Nkanga N
    Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):591-4. PubMed ID: 3143492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.